Inside the Reproductive Sciences Lab at the University of Colorado Anschutz Medical Campus in Aurora, researchers are on the ...
A common blood test for ovarian cancer is more likely to fall short for Black and Native American women, according to a new ...
Ovarian cancer, a leading cause of death among gynecological malignancies, has a poor prognosis and low 5-year survival rate, ...
A woman's story of literal strength shows how ovarian cancer can be missed—and the lighthearted recovery milestone every care ...
A new study finds that a common blood test for ovarian cancer may miss some Black and Native American patients, delaying ...
After you’ve gone through ovarian cancer treatment, your doctor will work with you to make sure you stay well. But sometimes the cancer returns. Doctors call this “recurrence.” To check for ...
A new drug tested in a phase 3 trial showed significant improvement in patients with treatment-resistant ovarian cancer.
Ovarian cancer—known as a silent killer due to its inability to showcase most of its symptoms—kills many women every year ...